• Mashup Score: 0

    General Description For those seeking core competencies and updates in heart failure care, this specific learning pathway features Maintenance of Certification (MOC) credits and includes eight (8) key sessions from the HFSA Annual Scientific Meeting 2022. With the 2022 HFSA ASM Core Learning Pathway, learners…

    Tweet Tweets with this article
    • Looking to earn valuable CME/CNE/CPE/MOC credits from 8 key sessions held at ASM 2022? The ASM Core Learning Pathway has you covered at only $99 for members! Topics include Heart transplant allocation, DELIVER trial and more! https://t.co/uOzSE6Hq7r #HFSA2022 https://t.co/GwVDzJpjFN

  • Mashup Score: 0

    Author Names If an author’s name appears on more than one abstract, it must be identical on each abstract. The submitting author is designated as the presenting or primary author – the presenting   author is shown in green in Oasis. The senior author must always be listed last. Abstract Data The Heart Failure Society of America is a forum for presentation of novel research findings….

    Tweet Tweets with this article
    • We are reminiscing on the incredible display of abstracts at #HFSA2022! Interested in highlighting your research at the 2023 Annual Scientific Meeting? The deadline for submissions is April 4th! Learn More >>https://t.co/OAKJji5DX6 #HFSA2023 https://t.co/eyIAPjRgGv

  • Mashup Score: 1

    Over 2,600 heart failure professionals gathered in person and virtually at the HFSA Annual Scientific Meeting 2022. Please see details below, for OnDemand access and purchase options.

    Tweet Tweets with this article
    • If you're looking for core competencies/updates in #heartfailure care, the new ASM learning pathways might be just what you're seeking - offering CE credits and key sessions from #HFSA2022! #CardioTwitter Learn more >> https://t.co/FrVJ2IDmXu

  • Mashup Score: 0

    The 2022 HFSA Annual Scientific Meeting bundle contains recordings of scientific sessions held during the HFSA Annual Scientific Meeting 2022. Learners can view recorded presentations to enhance their knowledge and learn the latest in heart failure care, treatment, research, and more. Continuing education credits are available for this product. This educational activity is designed for HFSA’s…

    Tweet Tweets with this article
    • Having FOMO from #HFSA2022? ASM is now available OnDemand! The bundle contains recordings of scientific sessions held during the HFSA ASM 2022. Learners can view recorded presentations to enhance their knowledge and learn the latest in HF care. https://t.co/ByZMxlA63l https://t.co/AoSX8bP2rM

  • Mashup Score: 1

    The 2022 HFSA Annual Scientific Meeting bundle contains recordings of scientific sessions held during the HFSA Annual Scientific Meeting 2022. Learners can view recorded presentations to enhance their knowledge and learn the latest in heart failure care, treatment, research, and more. Continuing education credits are available for this product. This educational activity is designed for HFSA’s…

    Tweet Tweets with this article
    • Did you miss out on #HFSA2022? Here's your chance to catch up! Gain access to more than 40 sessions, including each daily plenary session for one, full year PLUS credit opportunities! Learn more >> https://t.co/ByZMxlA63l https://t.co/Ej7Smoaoil

  • Mashup Score: 1

    The gains appeared early after the start of aficamten and persisted in tandem with significant echo and biomarker responses throughout the cohort study’s 6-month follow-up.

    Tweet Tweets with this article
    • Patients with obstructive HCM who took the myosin inhibitor aficamten showed major improvements in HF symptoms, functional capacity, hemodynamics, and quality of life in an observational cohort study. #HFSA2022 #CardioTwitter https://t.co/8A9rld47PS

  • Mashup Score: 0

    Should HF with improved LVEF be treated more like HFrEF or HFpEF? There are scant clinical trial data to help answer that, but a post-hoc analysis from a major trial may shed some light.

    Tweet Tweets with this article
    • In an era when LVEF has become less critical for guiding drug therapy for some patients with HF, it remains helpful for defining HF categories, even as it complicates the lexicon. #HFSA2022 #CardioTwitter #DELIVERTrial https://t.co/99sDmq3aBL

  • Mashup Score: 0

    NATIONAL HARBOR, Md. — Oral sodium chloride supplementation during IV diuresis resulted in similar changes in serum creatinine and body weight at 96 hours vs. placebo in patients hospitalized for acute HF, a speaker reported.The results of the Oral Sodium to Preserve Renal Efficiency in Acute HF (OSPREY-AHF) trial were presented at the Heart Failure Society of America Annual Scientific

    Tweet Tweets with this article
    • ICYMI: “We believe that the null result of this study does challenge the routine practice of sodium chloride restriction in acute heart failure, something done thousands of times a day, millions of times a year,” @ramontgo @HFSA #HFSA2022 #CardioTwitter https://t.co/0JtQOHJZVO